Skip to content
healthcare.dev
Get a free key

PYRAZINAMIDE

NDC 10135-735, pyrazinamide tablet, tablet, from MARLEX PHARMACEUTICALS, INC.

Product NDC
10135-735
Status
Listed
Labeler
MARLEX PHARMACEUTICALS, INC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA080157
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-735 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRAZINAMIDE500 mg/1

Pharmacologic classes

Antimycobacterial [EPC]

Package NDCNDC-11Package
10135-735-0110135073501100 TABLET in 1 BOTTLE (10135-735-01)
10135-735-601013507356060 TABLET in 1 BOTTLE (10135-735-60)
10135-735-901013507359090 TABLET in 1 BOTTLE (10135-735-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db250a85-2e20-87e9-e053-2a95a90a72b6

Use it

Look up 10135-735 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-735 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-735. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.